The Swiss stock market closed to the downside again Wednesday, extending modest losses from the previous session. Today's trading session was rather subdued, with low trading volume. Weakness in financial stocks and disappointing U.S. economic results also contributed to the negative mood.
The U.S. reported a lower than expected increase in durable goods orders for the month of February this afternoon. Financial stocks were under pressure early Wednesday, following the disappointing U.K. GDP report for the fourth quarter.
The Swiss Market Index fell by 0.30 percent Wednesday and finished at 6,250.43. The Swiss Leader Index closed down by 0.53 percent and the Swiss Performance Index dipped by 0.40 percent.
UBS fell by 1.5 percent Wednesday and Julius Baer declined by 0.8 percent. Credit Suisse managed a modest gain of 0.1 percent. Insurance stocks were also weak today. Swiss Re dropped by 0.8 percent, dragged lower by a study which came to the conclusion that the 2011 accident year is the second most expensive in history.
Shares of Nestle declined by 0.40 percent after UBS downgraded its rating on the stock to "Neutral" from "Buy." Roche finished the session higher by 0.9 percent and Novartis closed unchanged.
For comments and feedback contact: editorial@rttnews.com
Market Analysis
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.